Notícias Sobre o Forex

Swiss Market Ends Weak

Save for a few minutes early on in the session, the Switzerland market stayed in negative territory on Wednesday as investors remained reluctant to make significant moves, choosing to wait for directional cues.
RTTNews | 582 dias atrás
European Markets Close Higher On Rate Cut Hopes

European Markets Close Higher On Rate Cut Hopes

European markets, back to business after a long weekend, closed mostly higher on Wednesday, amid expectations the Federal Reserve will likely cut interest rates in March 2024. Several other central banks are also widely expected to ease their policy tightening to spur growth.
RTTNews | 582 dias atrás
Pound Advances On Rate Cut Expectations

Pound Advances On Rate Cut Expectations

The pound firmed against its major counterparts in the European session on Wednesday, as European stocks rose on hopes that major central banks will lower borrowing costs early next year.
RTTNews | 582 dias atrás
Codexis Inks Purchase Deal With Nestle Health Science For CDX-7108

Codexis Inks Purchase Deal With Nestle Health Science For CDX-7108

Enzyme engineering company Codexis, Inc. (CDXS) announced Wednesday it has entered into a purchase agreement with Nestle Health Science for CDX-7108, an investigational therapy for the potential treatment of exocrine pancreatic insufficiency (EPI).
RTTNews | 582 dias atrás
Surf Air Mobility Appoints Oliver Reeves To Succeed Deanna White As New CFO

Surf Air Mobility Appoints Oliver Reeves To Succeed Deanna White As New CFO

Air mobility platform Surf Air Mobility Inc. (SRFM) announced Wednesday that Oliver Reeves will join the Company as Chief Financial Officer. Reeves will lead the Company's financial and capital markets strategies leveraging his nearly two decades of experience in the investment management, enterprise technology, and insurance industries.
RTTNews | 582 dias atrás
more news
NKGen Biotech Receives Clearance For SNK01 NK Cell Therapy Clinical Trial From Health Canada

NKGen Biotech Receives Clearance For SNK01 NK Cell Therapy Clinical Trial From Health Canada

Biotechnology company NKGen Biotech Inc. (NKGN) announced Wednesday that it has received a No Objection Letter from Health Canada for its Clinical Trial Application for a Phase 1/2a study to evaluate the safety, tolerability, and exploratory efficacy of SNK01 natural killer cell therapy for the treatment of patients with moderate Alzheimer's Disease.
RTTNews | 582 dias atrás
Zevra Therapeutics Resubmits Arimoclomol NDA To FDA

Zevra Therapeutics Resubmits Arimoclomol NDA To FDA

Zevra Therapeutics, Inc. (ZVRA) announced Wednesday it resubmitted its New Drug Application (NDA) for arimoclomol to the U.S. Food and Drug Administration (FDA) on December 22, 2023. Arimoclomol is an investigational therapeutic candidate for the treatment of Niemann-Pick disease type C (NPC).
RTTNews | 582 dias atrás
Rate Cut Hopes Propel CAC-40 Higher

Rate Cut Hopes Propel CAC-40 Higher

The CAC-40 gained tracking European peers as well as Asian and Wall Street markets that traded on a positive note.
RTTNews | 582 dias atrás

Stay up to date!

Add Notícias to your browser

Extension Picture